| |
| |
|
| Insider
Information: |
Doshi Dipal |
| Relationship: |
CEO, Director |
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
342,081 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$18,101 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
342,081 |
|
|
| Total
Value |
$18,101 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amicus Therapeutics Inc |
FOLD |
SVP Strategy & Bus Dev |
2015-07-08 |
1,706 |
2014-07-07 |
0 |
Premium* |
|
|
Entrada Therapeutics, Inc. |
TRDA |
CEO, Director |
2024-03-05 |
340,375 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
51 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FOLD |
Amicus Therapeutics Inc |
SVP Business Planning & Dev |
• – – |
2014-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP Strategy & Bus Dev |
• – – |
2015-07-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
12,500 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP Strategy & Bus Dev |
• – – |
2015-07-07 |
4 |
D |
$14.10 |
$64,070 |
D/D |
(4,544) |
7,956 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP Strategy & Bus Dev |
• – – |
2015-07-08 |
4 |
AS |
$13.87 |
$86,689 |
D/D |
(6,250) |
1,706 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
President and CEOOfficer |
• • – |
2021-10-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
174,460 |
|
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
President and CEO |
• • – |
2022-01-13 |
4 |
OE |
$1.74 |
$17,400 |
D/D |
10,000 |
184,460 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
President and CEO |
• • – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,250 |
214,710 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
President and CEO |
• • – |
2022-06-27 |
4 |
AS |
$12.00 |
$48,000 |
D/D |
(4,000) |
210,710 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
President and CEO |
• • – |
2022-07-27 |
4 |
AS |
$12.00 |
$24,000 |
D/D |
(2,000) |
208,710 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
President and CEO |
• • – |
2022-08-29 |
4 |
AS |
$12.56 |
$21,103 |
D/D |
(1,639) |
207,071 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
President and CEO |
• • – |
2022-08-30 |
4 |
AS |
$12.00 |
$2,280 |
D/D |
(190) |
206,881 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
President and CEO |
• • – |
2022-08-31 |
4 |
AS |
$12.00 |
$2,052 |
D/D |
(171) |
206,710 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
President and CEO |
• • – |
2022-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,125 |
221,835 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
President and CEO |
• • – |
2022-09-08 |
4 |
AS |
$15.16 |
$16,673 |
D/D |
(1,100) |
220,735 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
President and CEO |
• • – |
2022-09-09 |
4 |
AS |
$15.07 |
$10,366 |
D/D |
(688) |
220,047 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
President and CEO |
• • – |
2022-09-15 |
4 |
AS |
$15.04 |
$3,008 |
D/D |
(200) |
219,847 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
President and CEO |
• • – |
2022-09-21 |
4 |
AS |
$15.12 |
$51,425 |
D/D |
(3,402) |
216,445 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
President and CEO |
• • – |
2022-09-23 |
4 |
AS |
$15.07 |
$15,413 |
D/D |
(1,023) |
215,422 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
President and CEO |
• • – |
2022-09-26 |
4 |
AS |
$15.22 |
$47,225 |
D/D |
(3,083) |
212,339 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
President and CEO |
• • – |
2022-09-27 |
4 |
AS |
$15.04 |
$67,220 |
D/D |
(4,419) |
207,920 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
President and CEO |
• • – |
2022-09-28 |
4 |
AS |
$15.23 |
$46,997 |
D/D |
(3,085) |
204,835 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
President and CEO |
• • – |
2022-10-20 |
4 |
AS |
$18.01 |
$14,607 |
D/D |
(811) |
204,024 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
President and CEO |
• • – |
2022-10-21 |
4 |
AS |
$18.28 |
$50,917 |
D/D |
(2,786) |
201,238 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
President and CEO |
• • – |
2022-10-24 |
4 |
AS |
$18.90 |
$45,189 |
D/D |
(2,342) |
198,896 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
President and CEO |
• • – |
2022-10-25 |
4 |
AS |
$20.01 |
$249,187 |
D/D |
(12,061) |
186,835 |
0 |
- |
|
51 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
